New Stem Cell State

Through cellular reprogramming, researchers have produced a novel pluripotent mouse stem cell in vitro.

Written byAnna Azvolinsky
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

F-class cellsLUNENFELD-TANENBAUM RESEARCH INSTITUTE/PETER D. TONGEResearchers from Mount Sinai Hospital’s Lunenfeld-Tanenbaum Research Institute and their international colleagues have uncovered a new type of pluripotent mouse stem cell—the “F-class” cell—through use of a somatic cell reprogramming approach. An F-class cell is able to differentiate into all three embryonic precursor tissues, yet is phenotypically and molecularly different from previously characterized induced pluripotent stem cells (iPSCs) made from somatic cells. These F-class cells proliferate more quickly than other stem cells in vitro, and are characteristically low-adhesion, giving them a fuzzy appearance. The results are published today (December 10) in Nature.

“What I find particularly exciting is that this opens up the idea that there may be different kinds of pluripotent stem cells,” said Paul Knoepfler, a stem cell biologist at the University of California, Davis, who was not involved in the work.

Juan Carlos Izpisua Belmonte, a developmental biologist at the Salk Institute for Biological Studies in La Jolla, California, who penned an accompanying editorial, agreed. “These studies and our understanding of embryo development teach us that we shouldn’t assume the known pluripotent stem cells represent the whole spectrum of pluripotency. Rather, there exists a multitude of pluripotent states or novel pluripotent states can be engineered through cellular reprograming,” Belmonte told The Scientist in an e-mail.

A second Nature paper published today provides a detailed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery